Treatment of Intractable Common Extensor Tendon Injury Using Mesenchymal Stem Cells (Allo-ASC)

NCT03449082 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Lateral Epicondylitis

Interventions

BIOLOGICAL: High concentration of Allo-ASC
BIOLOGICAL: Low concentration of Allo-ASC
DRUG: Fibrin glue
DRUG: Normal saline

Sponsor

Seoul National University Hospital

Collaborators

[object Object]